Internal Medicine Department, Fuenlabrada University Hospital, Madrid, Spain.
Eur J Intern Med. 2013 Sep;24(6):541-5. doi: 10.1016/j.ejim.2013.05.010. Epub 2013 Jun 12.
Although much has been written about bacteremia, evidence of the clinical diagnostic accuracy of bacteremia sources in the absence of microbiological results and the impact of diagnostic accuracy on mortality is scarce.
This is a retrospective study of bacteremia episodes over a 2-year period at a general hospital in Madrid. Congruence analyses between clinically presumed and definite sources, acquisition, causative organism, empirical treatment and progression to death were performed.
The study included 323 bacteremia episodes. Clinicians' diagnostic accuracy was higher for gastrointestinal (88.8%; 95% CI: 79%-84%), respiratory (93.9%; 95% CI: 79%-99%) and urinary tract sources (83.6%; 95% CI: 75%-89%) and lower for skin and soft tissues (77.2%; 95% CI: 54%-92%) and, notably, intravascular sources (56%; 95% CI: 39%-71%). Overall, a non-significant (3.45%; 95% CI: -0.6%-13.5%, p=0.47) increase in mortality was observed in the incorrectly suspected bacteremia source group. Mortality related to a definitive source was significantly higher when an intravascular origin was not suspected, resulting in a 26% increase in mortality (95% CI: 1%-52%, p=0.03). Differences in mortality related to inaccurate source assumptions were non-significant when the definitive bacteremia sources were gastrointestinal, urinary, respiratory, skin and soft tissues or unknown. Mortality in the group receiving appropriate empirical antimicrobial treatment was 10.6% compared with 19.7% mortality in the group receiving inappropriate empirical antimicrobial treatment (OR 2; 95% CI: 1.01-4.25).
The diagnostic accuracy of bacteremia sources is high in all but intravascular sources. A non-suspected intravascular source and inappropriate empirical treatment are related to a higher mortality.
尽管已有大量关于菌血症的文献,但在缺乏微生物学结果的情况下,菌血症来源的临床诊断准确性及其对死亡率的影响证据仍然有限。
这是一项在马德里一家综合医院进行的为期 2 年的菌血症发作回顾性研究。对临床推测和确定的来源、获得途径、病原体、经验性治疗以及进展为死亡之间的一致性进行了分析。
该研究共纳入 323 例菌血症发作。胃肠(88.8%;95%CI:79%-84%)、呼吸(93.9%;95%CI:79%-99%)和尿路来源(83.6%;95%CI:75%-89%)的临床诊断准确性较高,而皮肤和软组织(77.2%;95%CI:54%-92%)和血管内来源(56%;95%CI:39%-71%)的临床诊断准确性较低。总体而言,在错误怀疑菌血症来源组中,死亡率观察到非显著增加(3.45%;95%CI:-0.6%-13.5%,p=0.47)。当未怀疑血管内来源时,与明确来源相关的死亡率显著更高,导致死亡率增加 26%(95%CI:1%-52%,p=0.03)。当明确的菌血症来源为胃肠、泌尿、呼吸、皮肤和软组织或未知时,不准确的源假设与死亡率之间的差异无统计学意义。接受适当经验性抗菌治疗的患者死亡率为 10.6%,而接受不适当经验性抗菌治疗的患者死亡率为 19.7%(OR 2;95%CI:1.01-4.25)。
除血管内来源外,所有其他菌血症来源的临床诊断准确性均较高。未怀疑血管内来源和不适当的经验性治疗与更高的死亡率相关。